Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesParagangliomas: Etiology, Presentation, and Management
Cardiology In Review, 06/19/09
Joynt KE et al. - Paragangliomas are catecholamine-secreting tumors arising from the chromaffin cells of the sympathetic ganglia. These tumors commonly present with episodic hypertension, tachycardia, headache, and diaphoresis, and can be either benign or malignant. Management of paraganglioma is predicated on surgical resection, and careful perioperative management with alpha- and beta-adrenergic blockade is imperative for optimal outcomes. The majority of these tumors are benign, but for patients with malignant disease, chemotherapy, and radiation therapy may provide modest benefit.
Related Articles
Parasympathetic Paragangliomas Are Part of the Von Hippel-Lindau Syndrome
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 88%
Composite paraganglioma-ganglioneuroma in the retroperitoneum
World Journal of Surgical Oncology, 11/09/09
Relevance Score: 84%
Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea
Yonsei Medical Journal, 10/30/09
Relevance Score: 84%
Endoglin as a marker in cervical paragangliomas
Head & Neck, 10/15/09
Relevance Score: 83%
Paragangliomas of head and neck: a treatment option with CyberKnife radiosurgery
Neurological Sciences, 10/08/09
Relevance Score: 83%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of the Perifornical Hypothalamic Monoamine Neurotransmitter Systems in Anorectic Effects of Endotoxin
Neuroendocrinology, 12/01/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/04/09
Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09
Sponsor
Article Search
Sponsor